RE: Milestone payment schedule(Proposed?)This back-end loaded milestone payment schedule speaks volume as to what ENDO has in mind.
Pay out as little as possible to get their foot in. Buy out the MCC - bladder platform as soon as Phase IIIb results shows FDA approval solid and before the rest of the payments are due.
Just hope the weak hands won't fall for the traps and drop the sp so low that ENDO can pick it up for nothing. The next two years are crucial for share-holders to hold up the sp. Lets hope something positive will come out of the animal health or food safety divisions to prop up the sp.
Those of us who holds firm will come into good money. How much will depend on how many of us become impatient and prematurely sell out, thus dropping the sp and give ENDO an easy picking.